These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 7898965

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Surfactant replacement therapy improves ventilation inhomogeneity in infants with respiratory distress syndrome.
    Sandberg KL, Lindstrom DP, Sjöqvist BA, Parker RA, Cotton RB.
    Pediatr Pulmonol; 1997 Nov; 24(5):337-43. PubMed ID: 9407567
    [Abstract] [Full Text] [Related]

  • 3. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML, Llanas B, Apere H, Fayon M, Galperine RI, Guenard H, Demarquez JL.
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [Abstract] [Full Text] [Related]

  • 4. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V.
    N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
    Dechant KL, Faulds D.
    Drugs; 1991 Nov 12; 42(5):877-94. PubMed ID: 1723378
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV.
    J Perinatol; 1997 Nov 12; 17(6):455-60. PubMed ID: 9447532
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ, Glover RM, Parry GJ, Wilkie RA, Laing IA, Tarnow-Mordi WO.
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan 12; 70(1):F19-24. PubMed ID: 8117122
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of two rescue doses of synthetic surfactant in 344 infants with respiratory distress syndrome weighing 750 to 1249 grams: a double-blind, placebo-controlled multicenter Canadian trial. Canadian Exosurf Neonatal Study Group.
    McMillan D, Chernick V, Finer N, Schiff D, Bard H, Watts J, Krzeski R, Long W.
    J Pediatr; 1995 May 12; 126(5 Pt 2):S90-8. PubMed ID: 7745517
    [Abstract] [Full Text] [Related]

  • 19. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan 12; 97(1):1-6. PubMed ID: 8545199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.